Aim: Vacuum-assisted closure (VAC) was primarily designed for the treatment of pressure ulcers or chronic, debilitating wounds. Recently, VAC has become an encouraging treatment modality for sternal wound infection after cardiac surgery, providing superior results to conventional treatment strategies.
INTRODUCTION
Sternal wound infection following cardiac procedures occurs in 1 to 5 % of cases and represents a serious problem involving prolonged hospitalization, increased hospital costs, and increased morbidity and mortality [1] [2] [3] [4] . Conventional treatment modalities usually involve surgical debridement with open dressing or closed irrigation or delayed reconstruction 5, 6 . The vacuum-assisted closure (VAC) system was introduced into clinical practice for the treatment of pressure ulcers and chronic debilitating wounds in 1997 7 . Recent studies have reported the eff ectiveness of the VAC system in the treatment of sternal wound infection in cardiac surgery, with emphasis on the treatment of deep sternal wound infection [8] [9] [10] [11] .
Patients and methods
From November 2004 to September 2006, 34 patients, undergoing VAC therapy for sternal wound infection following cardiac surgery, were prospectively evaluated. Data obtained from medical records included demographic characteristics are presented in Table 1 . The type of cardiac procedure, time interval of wound infection presentation after the procedure, time of VAC therapy, the number of dressing changes and length of hospitalization are summarized in Table 2 . Ten patients (29 %) were treated for superfi cial sternal wound infection (SSWI) and twentyfour (71 %) for deep sternal wound infection (DSWI).
Sternal wound infection classifi cation and predictors of increased risk factor for sternal wound infection
Sternal wound infection was defi ned according to the guidelines of the Centre for Disease Control and Prevention (CDC) 12 . Involvement of skin or subticular tissue was defi ned as a SSWI, involvement of deeper tissue such as a pectoral fascia, sternal bone as well as mediastinal space was classifi ed as a DSWI. Diagnosis of sternal wound infection required at least one of the following criteria: (1) an organism was isolated from the culture or mediastinal fl uid; (2) evidence of wound infection during the operation and (3) one of the following conditions: chest pain, sternal instability, or fever (>38 °C) accompanied by either purulent discharge from the mediastinum or an organism isolated from the blood culture or culture of drainage from the mediastinal space 11 . The simplifi cation of the traditional Oakley-Wright classifi cation of DSWI based on the time of presentation and the presence of risk factors was adopted by the authors 13 . A DSWI occurring within 2 weeks after the operation was classifi ed as type I and a DSWI present 2 to 6 weeks after the operation as type II. Finally, a DSWI present for the fi rst time more than 6 weeks after the procedure was classifi ed as type III. Detailed wound classifi cation types are shown in Table 3 . Predictors of increased risk of DSWI included: (1) obesity, (2) pedicled bilateral internal mammary artery grafts in diabetics, prolonged operative time and (4) need for repeated blood transfusion in the early post-operative period 3, 4 . Extensive and/or massively discharging SSWI requiring frequent dressing changes was primarily managed by the VAC system. In the treatment of the DSWI, the VAC system was initially employed as a treatment modality for failed conventional treatments involving one-step wound debridement, sternal rewiring and application of closed drainage. Later, when the technique was well mastered, the VAC system was routinely used as a fi rst-line treatment for DSWI as well. The identical therapeutic algorithm was adopted for all sternal wound infections. Necrotic tissue and foreign materials were debrided under aseptic conditions and the wound bed was massively irrigated with normal saline solution (Figure 1 ). Sterile polyurethane foam dressing, with a defi ned pore structure of 400 to 600 μm (Granufoam ® , KCI, Vienna, Austria), was trimmed to fi t between the wound edges. In the case of DSWI, a layer of non-adhesive dressing was applied to the anterior aspect of the heart to protect the free wall of the right ventricle and/or conduits. Subsequently, foam was placed in two layers, on the one placed under the sternal edges the second was superimposed to fi ll up the whole wound cavity. Tubing was applied to the foam dressing (TRACpad ® , KCI, Vienna, Austria) and the wound was sealed with a transparent adhesive drape ( Figure 2 ). The drainage tube was connected to a purpose-built vacuum source (VAC ATS ® pump unit; KCI, Vienna, Austria). The VAC device is able to generate continuous or intermittent negative pressure variations from 50 to 250 mm Hg. The target subatmospheric pressure is monitored and maintained at the wound site, even during the patient's movement and breathing. Exudates from the wound were collected into a canister embedded into the pump unit. Initially, 50 mm Hg of negative pressure was applied to the adjunct of the foam to the wound geometry. The therapy was subsequently targeted to 125 mm Hg continuous negative pressure. The polyurethane foam dressing was changed every 48 to 72 hours. The wound was repeatedly, gently debrided, irrigated with a saline solution and covered in Vacuum-assisted closure in the treatment of sternal wound infection after cardiac surgery the same fashion. At least two bacteriological culture samples from the wound were obtained during each dressing change. In case of the DSWI, the wound bed preparation and foam placement were carried out under a short period of general anaesthesia. The patients were extubated immediately after the procedure, if their general condition allowed it. Meticulous nutritional support as well as tight intravenous insulin management was ensured. The antibiotic treatment was given according to the sensitivity of the bacteriological strains and the clinical response of the patient. All patients received a prolonged course of culture-dependent intravenous antibiotics during the VAC treatment. Antibiotics were discontinued when the healing process and parameters of infl ammation had diminished except from DSWI when oral antibiotics were continued for 4 weeks after the wound closure. Wound culture characteristics are summarized in Table 4 . The wound was considered to be free of any infection according to advanced local signs of the healing process including the formation of well-vascularised granulation tissue together with negative bacteriological cultures ( Figure 3) . Further, the decline in serological infl ammatory parameters, particularly the C-reactive protein level less than 50 mg/l was required for termination of the VAC therapy. Since excessive residual defects remained, all patients were subsequently indicated for the reconstructive procedure.
RESULTS
Complete healing was achieved in 33 patients (97 %). One patient suff ering from DSWI died (3 %) of multiple organ failure on the 24 th postoperative day, despite achieving negative bacteriological cultures during the therapy. The hospital stay ranged from 9 to 62 days (median 34.6 days). Median of the SSI presentation after cardiac procedure was 16 days (range 4 to 52 day). Sixteen (47 %) patients were re-admitted to our department due to sternal infection despite uneventful wound healing at the time of discharge. The median VAC treatment time until surgical closure was 9.2 days (range 6 to 21 days). The wound defects after VAC therapy were managed either by direct wound closure or by local fasciocutaneous and/or myocutaneous advancement fl aps based on the size of the residual defect to ensure tension-free closure. In the SSWI group, one partial superfi cial wound dehiscence after the direct closure was recorded. In addition, one patient was re-admitted for sinus tract formation 6 months after the VAC therapy. Both patients were successfully healed by debridement and major pectoral myocutaneous fl ap transfer. In the DSWI group, seven patients (29 %) were switched to VAC therapy after failure of the conventional treatment strategy. Afterwards, based on increasing experience, 17 patients with DSWI (71 %) were scheduled for the VAC system application as a fi rst-line procedure. In an eff ort to preserve chest stability, the subsequent reconstructive procedure in this group involved either complete or partial sternum rewiring, depending on the sternal mass loss during debridement. Simultaneously, any residual soft tissue defect was covered by bilateral major pectoral myocutaneous advancement fl ap in all cases of DSWI. One partial wound dehiscence was noted in the distal part of sternotomy and managed by a delayed direct wound closure. In addition, 2 patients (6 %) were re-admitted 1 to 6 months after wound closure due to wire-associated chronic sinus tract formation. One or more independent risk factors for the sternal wound infection development were presented in all patients (Table 1) . Staphylococcus aureus and coagulase-negative staphylococcus dominated in the spectrum of organisms cultivated from wounds (Table 3) , but, no methicilline-resistant staphylococcal strains were cultivated. There was no signifi cant diff erence in outcome based on etiological causative agent. The continuous VAC therapy reaching subatmospheric pressure up to 125 mm Hg caused no patient discomfort. No VAC device-related complications were noted.
DISCUSSION
The VAC system was initially designed to treat chronic or debilitating wounds 7 . Since the fi rst use of VAC therapy in 1989, this treatment modality has rapidly evolved into a widely accepted treatment for chronic and acute wounds, contaminated wounds, burns, and wound complications from unsuccessful operations 8 . The system combines the benefi ts of both closed and open wound Escherichia coli 1 3 Pseudomonas aeruginosa 3 9 Klebsiela oxytoca 1 3 MRSA 0 0
CoNS -coagulase negative staphylococcus MRSA -methiciline-resistant staphylococcus treatment. On one hand, the controlled application of subatmospheric pressure to the wound approximates the wound edges and provides a mass fi lling eff ect. On the other hand, it has a positive eff ect in several wound healing processes. It produces arteriolar dilatation, improves microcirculatory fl ow, reduces wound oedema and bacterial colonization 7, 8, 14, 15 . Generally, it leads to signifi cant acceleration of granulation tissue formation 7, 8, 15 . Sternal wound infections remain some of the most feared complications in cardiac surgery. Growing experience with VAC treatment in the fi eld of cardiac surgery is showing its over the conventional treatment of sternal infections including either one-step surgical debridement, sternal rewiring and closed mediastinal drainage or repeated debridement, open packing and subsequent sternal reconstruction 8-11, 16, 17 . In the VAC group, freedom from mediastinal microbiological cultures was achieved earlier, C-reactive protein level declined more rapidly, in-hospital stay was shorter, sternal closure was achieved earlier and long-term survival tended to be higher [17] [18] [19] [20] . VAC therapy markedly reduced required surgical intervention and reoperations for persistent infections, even in the group of high-risk patients 19 . Beyond the positive eff ect of the VAC on the local wound healing process, the foam becomes fi rm through application of subatmospheric pressure and acts as a splint for the sternum 10, 11 . This enables mobilization of the patients and allows them either to breathe spontaneously or to be weaned from artifi cial ventilation during the inherent therapy 8, 11 . Further, the stabilisation of the remaining sternal edges may be helpful in preventing right ventricular or conduit injury [8] [9] [10] . VAC therapy was primarily used as a bridge to allow cleaning and preparation of the wound bed for further reconstruction 8, 10, 11 . Use of the VAC therapy as a defi nitive closure strategy has been recently reported 8, 21 . This approach seems to be mostly benefi cial in high-risk patients, where it reduces dependence on regional fl ap and incidence of fl ap-related morbidity, or in cases of SSWI. Nevertheless, this approach is associated with time extension for the VAC treatment as well as increased cost 21 . Traditionally, timing of the following surgical closure is based on the appearance of the wound, negativity of wound cultures and general patient condition. However, the VAC therapy, Vacuum-assisted closure in the treatment of sternal wound infection after cardiac surgery guided by C-reactive protein level, facilitates timing of wound closure, decreased morbidity and increased costeff ectiveness of the procedure 22 . Decline in C-reactive protein levels below 50 mg/l can be considered a safe trigger for wound closure timing within the institutional algorithm 23 . The authors present their fi rst experience with VAC treatment for sternal wound infections following cardiac surgery. Despite the limited patient cohort, inhomogeneous group of patients and nonrandomized design, VAC therapy was eff ective and suitable, particularly in the presence of risk factors such as obesity, diabetes, bilateral internal mammary artery grafting and immunosuppressive therapy. The positive eff ect of subatmospheric pressure on the local wound healing process, active wound drainage and approximation of the wound edges was advantageous. In the case of DSWI, the VAC system allow us to perform wound debridement repeatedly under brief general anaesthesia and subsequently enabled, due to the stabilizing eff ect on the sternal halves, spontaneous ventilation and early mobilization of patients. VAC therapy was used as a bridge to defi nitive surgical closure in all cases. Regarding the extent of tissue loss, the tension-free closure technique was widely accepted with the use of local advancement fl aps to cover residual soft tissue defects if needed 24 . However, the sternum-sparing approach, including sternum rewiring for preservation of chest stability, may be associated with later risk of wire-related, chronic sinus tract formation 25 .
CONCLUSION
The VAC system is a safe and reliable option in the treatment of extensive wound sternal infection in cardiac surgery, mainly promising as the fi rst-line treatment for DSWI, with excellent survival and low failure rate.
